OakChart

Kodiak Sciences Inc

KODHealthcare·Biotechnology·USA·Mid·NASD·Nov 11 • 3:59 PM ET

109.34+1.28 (1.18%)
2026-11-12 03:33 CET
Market cap
6,871.96 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-241.99 USD m
Free cash flow, TTM
-159.90 USD m
EPS diluted, TTM
-4.19
P/E
-
Compare

Price

KOD against its 20, 50 and 200-day averages
2050200miss
25.0050.0075.00100.0019.3M38.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26KODclose 109.3420-day 95.3450-day 73.81200-day 45.09109.3452w low

2.6% under the 52-week high of 112.31 on 11 Nov 2026. 52-week low 18.05 on 13 Nov 2025. Last 15 sessions, 35.1% high to low

Volume 0.40× normal · the line is the 50-bar volume average

Profile

KOD
52-week range, 100% of the way up
18.05109.2

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

IndexRUT
Employees124
IPOOct 04, 2018
Beta1.97
ATR, 14d6.54
Rel volume0.40
Short float14.12%
Insider own8.55%
Inst own103.56%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap6.87B
Enterprise Value6.90B
Income-241.99M
Sales0.00M
Book/sh0.97
Cash/sh2.00
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees124
IPOOct 04, 2018

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B112.44
P/C54.58
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio2.49
Current Ratio2.49
Debt/Eq2.50
LT Debt/Eq2.34
Option/ShortYes / Yes

Earnings

EPS (ttm)-4.19
EPS next Y-3.85
EPS next Q-1.06
EPS this Y5.58%
EPS next Y5.61%
EPS next 5Y50.98%
EPS past 3/5Y12.22% -8.23%
Sales past 3/5Y- -
EPS Y/Y TTM-10.60%
Sales Y/Y TTM-
EPS Q/Q-1.85%
Sales Q/Q-
EarningsAug 13 AMC
EPS/Sales Surpr.-9.78% -

Ownership

Insider Own8.55%
Insider Trans65.61%
Inst Own103.56%
Inst Trans3.71%
ROA-94.25%
ROE-368.37%
ROIC-118.60%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA2014.69%
SMA5048.14%
SMA200142.52%
Trades-

Technical

Shs Outstand62.83M
Shs Float57.48M
Short Float14.12%
Short Ratio4.69
Short Interest8.12M
52W High109.20 0.13%
52W Low18.05 505.76%
Volatility7.36% 7.13%
ATR (14)6.54
RSI (14)68.38
Beta1.97
Rel Volume0.40
Avg Volume1.73M
Volume689,453

Performance

Perf Week10.99%
Perf Month19.33%
Perf Quarter173.49%
Perf Half Y176.04%
Perf YTD291.06%
Perf Year457.00%
Perf 3Y6256.98%
Perf 5Y-2.48%
Perf 10Y-
Recom1.33
Target Price121.67
Prev Close108.06
Price109.34
Change %1.18%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 24, 2026ResumedGGoldmanNeutral$36-67.1%
May 11, 2026UpgradeCChardan Capital MarketsNeutral → Buy$61-44.2%
Nov 11, 2025UpgradeHH.C. WainwrightNeutral → Buy$24-78.1%
Oct 24, 2025UpgradeJJP MorganNeutral → Overweight$24-78.1%
Sep 25, 2025UpgradeBBarclaysUnderweight → Equal Weight$17-84.5%
Sep 22, 2025InitiatedJJefferiesBuy$15-86.3%
Aug 14, 2025UpgradeJJP MorganUnderweight → Neutral$15-86.3%
Dec 09, 2024UpgradeJJefferiesHold → Buy$20-81.7%
Sep 05, 2024InitiatedHH.C. WainwrightNeutral$3-97.3%
Dec 11, 2023ResumedGGoldmanSell$2-98.2%

Peers

Mkt cap
TickerCompanyMkt cap
OCULOcular Therapeutix Inc1.47B
EYPTEyePoint Inc30.74M
FDMT4D Molecular Therapeutics Inc717.62M
REGNRegeneron Pharmaceuticals Inc99.23B
BLTEBelite Bio Inc ADR6.28B
RGNXRegenxbio Inc560.06M
OTLKOutlook Therapeutics Inc117.10M
OCGNOcugen Inc325.87M
ROIVRoivant Sciences Ltd30.32B
HROWHarrow Inc1.10B

Insider trading

latest 14 of 20
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
BAKER BROS. ADVISORS LPDirectorNov 04 '26Buy98.51160,65815,826,42020,343,130Nov 06 04:55 PM
BAKER BROS. ADVISORS LPDirectorNov 05 '26Buy98.5186,4328,514,41620,424,859Nov 06 04:55 PM
Yang TaiyinDirectorOct 23 '26Option Exercise2.3520,00047,00020,000Oct 26 05:00 PM
BORGESON JOHN A.Chief Financial OfficerOct 21 '26Option Exercise2.4930,00074,700241,930Oct 23 05:00 PM
BORGESON JOHN A.Chief Financial OfficerOct 21 '26Sale90.0130,0002,700,322211,930Oct 23 05:00 PM
JOHN BORGESONOfficerOct 21 '26Proposed Sale92.9730,0002,789,100Oct 21 04:21 PM
BAKER BROS. ADVISORS LPDirectorSep 28 '26Buy88.77681,86660,529,35420,159,386Sep 30 04:31 PM
BAKER BROS. ADVISORS LPDirectorSep 29 '26Buy85.0533,7262,868,25520,191,214Sep 30 04:31 PM
BAKER BROS. ADVISORS LPDirectorSep 28 '26Buy83.58418,32334,963,07719,515,907Sep 30 04:30 PM
BAKER BROS. ADVISORS LPDirectorSep 28 '26Buy72.57807,84058,625,70819,121,134Sep 30 04:29 PM
PERLROTH VICTORChairman and CEOSep 25 '26Option Exercise4.201,280,5245,381,9433,676,062Sep 29 07:44 PM
BORGESON JOHN A.Chief Financial OfficerJun 04 '26Option Exercise1.0430,00031,200241,930Jun 05 05:56 PM
BORGESON JOHN A.Chief Financial OfficerJun 04 '26Sale34.1030,0001,023,009211,930Jun 05 05:56 PM
JOHN BORGESONOfficerJun 04 '26Proposed Sale33.8730,0001,016,100Jun 04 04:29 PM

Held by

AUM
TickerCompanyAUM
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
IBBiShares Biotechnology ETFAUM: 11.36B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
TMSLT. Rowe Price Small-Mid Cap ETFAUM: 3.28B

News

latest 14 of 98

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-08-13-1.050-0.957-1.0500.000.005
2026Q12026-05-07-0.940-0.956-0.9400.000.005
2025Q42026-03-31-1.040-1.053-1.0420.000.006
2025Q32025-11-13-1.160-1.037-1.1630.000.007
2025Q22025-08-13-1.030-1.068-1.0290.000.005
2025Q12025-05-14-1.090-0.894-1.0890.000.005
2024Q42025-03-27-0.840-0.883-0.8380.000.005
2024Q32024-11-14-0.840-0.905-0.8350.000.006
2024Q22024-08-14-0.860-0.872-0.8590.000.005
2024Q12024-05-15-0.820-1.069-0.8200.000.006
2023Q42024-03-28-1.130-0.774-1.1340.000.006
2023Q32023-11-14-0.950-1.207-0.9530.000.007
2023Q22023-08-14-1.530-1.148-1.5310.000.006
2023Q12023-05-15-1.350-1.333-1.3520.000.008
2022Q42023-03-28-1.350-1.471-1.3470.000.009
2022Q32022-11-09-1.470-1.719-1.4730.000.009

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-1.250-1.190-1.2510.0016.67
2020FY-2.910-2.354-2.9100.0017.86
2021FY-5.160-4.700-5.1550.000.00
2022FY-6.390-6.567-6.3890.000.00
2023FY-4.970-4.596-4.9700.000.00
2024FY-3.350-3.394-3.3510.000.00
2025FY-4.320-4.268-4.3200.000.00
2026FY--4.079--0.00
2027FY--3.850--49.14
2028FY--0.509--375.3
2029FY-5.820--1,025
2030FY-9.630--1,597

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-09-254000.000.000.00
2026Q3S2026-09-233000.000.000.00
2026Q3S2026-08-142000.000.000.00
2026Q3S2026-08-132000.000.000.00
2026Q3S2026-07-312000.000.000.00
2026Q3S2026-07-301000.000.000.00
2026Q3S2026-07-102000.000.000.00
2026Q3S2026-05-083000.000.000.00
2026Q3S2026-04-012000.000.000.00
2026Q3S2026-02-111000.000.000.00
2026Q3S2025-11-142000.000.000.00
2026Q3S2025-11-111000.000.000.00
2026Q3S2025-11-101000.000.000.00
2026Q3R2026-11-08310-1.03-1.10-0.97

Estimate history

EPS, annual-0.761-2.767-1.251-2.91-5.155-6.389-4.97-3.351-4.322-4.1932
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.859-0.835-0.838-1.089-1.029-1.163-1.042-0.94-1.048
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0000000000
Period201720182019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual36.71636.8344.41351.11251.82652.33452.50952.72761.75862.831
Period201720182019202020212022202320242025MRQ
Shares, quarterly52.61552.62352.72752.75252.82252.99961.75862.15662.831
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A25.5826.3226.7125.9511.008.714.210.910.49
Gross Profit-25.58-26.32-26.71-25.95-11.00-8.71-4.21-0.91-0.49
Selling, General and Administrative Excl. Other220.84206.16160.14251.37330.38258.34131.8048.2825.88
Research and Development200.60182.37126.09206.30267.59217.34107.3937.5118.79
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-246.42-232.48-186.85-277.32-341.38-267.05-136.01-49.19-26.37
Interest Expense---0.010.020.020.030.015.52
Unusual Expense0.001.910.000.00--0.000.000.79
Net Income Before Taxes-241.99-229.97-176.21-260.49-333.82-266.99-133.10-47.37-41.44
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-241.99-229.97-176.21-260.49-333.82-266.99-133.10-47.37-41.44
Net Income From Continuing Operations-241.99-229.97-176.21-260.49-333.82-266.99-133.10-47.37-41.44
Net Income-241.99-229.97-176.21-260.49-333.82-266.99-133.10-47.37-41.44
EPS (Recurring)-3.86-4.30-3.35-4.97-6.39-5.16-2.91-1.25-2.73
EPS (Basic, Before Extraordinaries)-4.19-4.32-3.35-4.97-6.39-5.16-2.91-1.25-2.77
EPS (Diluted)-4.19-4.32-3.35-4.97-6.39-5.16-2.91-1.25-2.77
EBITDA-220.84-206.16-160.14-251.37-330.38-258.34-131.80-48.28-25.88
Non-Operating Income (Expense)4.434.4210.6416.847.570.082.941.83-8.76
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense51.0958.8660.2188.56106.0361.3830.676.112.61
Shares Outstanding62.8361.7652.7352.5152.3351.8351.1144.4136.83
Market Capitalization6,871.966,871.96523.61159.52374.534,384.597,459.462,666.32261.49

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A6.196.346.516.546.546.736.686.70
Gross Profit-6.19-6.34-6.51-6.54-6.54-6.73-6.68-6.70
Selling, General and Administrative Excl. Other60.6553.4450.9455.8148.9750.4539.5039.94
Research and Development56.0848.5545.4950.4842.7643.6431.7731.88
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-66.84-59.78-57.45-62.35-55.51-57.17-46.18-46.63
Unusual Expense0.000.000.000.000.001.900.000.00
Net Income Before Taxes-65.64-58.16-56.74-61.46-54.31-57.46-44.10-43.95
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-65.64-58.16-56.74-61.46-54.31-57.46-44.10-43.95
Net Income From Continuing Operations-65.64-58.16-56.74-61.46-54.31-57.46-44.10-43.95
Net Income-65.64-58.16-56.74-61.46-54.31-57.46-44.10-43.95
EPS (Recurring)-1.05-0.94-1.04-1.16-1.03-1.06-0.84-0.84
EPS (Basic, Before Extraordinaries)-1.05-0.94-1.04-1.16-1.03-1.09-0.84-0.84
EPS (Diluted)-1.05-0.94-1.04-1.16-1.03-1.09-0.84-0.84
EBITDA-60.65-53.44-50.94-55.81-48.97-50.45-39.50-39.94
Non-Operating Income (Expense)1.201.620.720.901.201.612.072.69
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense11.6112.1513.2914.0515.6415.898.6214.81
Shares Outstanding62.8362.1661.7653.0052.8252.7552.7352.62
Market Capitalization6,871.962,327.161,706.91864.69196.81147.61523.61137.32

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments209.86168.07285.51478.93731.51968.97336.4888.251.40
Short Term Receivables0.000.000.000.000.000.000.000.000.00
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets4.953.863.807.073.303.032.752.190.20
Total Current Assets214.82171.94289.31486.00734.81972.00339.2390.451.59
Net Property, Plant & Equipment121.86148.73175.02115.75108.0778.812.791.101.51
Total Investments and Advances6.186.186.326.326.326.3211.840.140.14
Intangible Assets---0.000.000.00--0.00
Other Assets8.678.738.7258.5555.0110.215.010.500.00
Total Assets351.53335.58479.37666.63904.221,067.35358.8792.193.24
Short Term Debt Incl. Current Port. of LT Debt12.0610.639.779.933.932.370.430.000.11
Accounts Payable12.863.9213.619.1312.438.652.621.053.36
Other Current Liabilities20.6111.0318.3533.4448.3220.408.663.785.69
Total Current Liabilities45.5325.5741.7352.5064.6831.4211.714.839.16
Long Term Debt147.12159.72171.86177.80176.0175.031.500.0011.51
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities1.500.000.000.160.21100.150.290.531.30
Total Liabilities194.15185.29213.59230.46240.90206.6013.515.3621.96
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.0050.02
Common Equity157.38150.29265.78436.17663.32860.75345.3686.83-68.74
Total Shareholders Equity157.38150.29265.78436.17663.32860.75345.3686.83-18.72
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity157.38150.29265.78436.17663.32860.75345.3686.83-18.72
Total Liabilities & Stockholders Equity351.53335.58479.37666.63904.221,067.35358.8792.193.24
Book Value Per Share2.552.855.068.3312.8016.847.782.36-1.87
Tangible Book Value Per Share2.552.855.068.3312.8016.847.782.36-1.87
Full-Time Employees1241091111129372392828
Price to Book Ratio112.442.820.530.786.628.729.253.01-2.60
Return on Assets-66.94-43.24-45.46-42.50-27.08-18.66-21.00-86.85-363.80
Return on Equity-149.49-84.70-74.22-60.72-35.04-22.07-21.92-121.69-
Return on Invested Capital-75.52-56.84-59.52-54.37-31.81-14.22-13.66-47.73-
Quick Ratio4.726.726.939.2611.3630.9328.9718.740.17
Current Ratio4.726.726.939.2611.3630.9328.9718.740.17

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-241.99-229.97-176.21-260.49-333.82-266.99-133.10-47.37-41.44
Depreciation25.5826.3226.7125.9511.008.714.210.910.49
Other Funds (Non Cash)51.1160.7960.5787.72104.4061.5830.675.8718.31
Funds from Operations-165.31-142.85-88.93-146.83-218.42-196.70-98.22-40.59-22.64
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital6.806.85-28.39-7.3611.9614.4314.791.44-6.39
Cash from Operating Activities-158.50-136.01-117.32-154.18-206.46-182.27-83.43-39.15-29.03
Capital Expenditures-1.40-0.51-0.40-41.43-47.36-63.30-7.00-0.44-0.58
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.00290.65-289.7724.50111.83-136.560.00
Purchase of Investments0.000.000.00-49.35-427.770.00-86.32-150.960.00
Sale Or Maturity of Investments0.000.000.00340.00138.0024.50198.1514.400.00
Other Uses0.000.00-0.350.000.000.000.000.000.00
Other Sources0.000.000.000.000.620.000.000.000.00
Cash from Investing Activities-1.40-0.51-0.76249.23-336.51-38.80104.83-137.00-0.58
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock181.64178.300.500.241.948.23618.26299.7783.80
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock181.64178.300.500.241.948.23618.26299.7783.80
Proceedsfrom Stock Options172.86173.140.110.180.170.48612.02297.4883.75
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00-0.01-0.0532.75
Change in Long Term Debt0.000.000.000.000.000.00-0.01-0.0532.75
Issuance of Long Term Debt0.000.000.000.000.000.000.000.0032.86
Reduction of Long Term Debt0.000.000.000.000.000.00-0.01-0.05-0.11
Net Financing Active Other Cash Flow0.000.000.00-0.21-0.05-0.0499.12-0.04-0.09
Other Financing Activities Uses0.000.000.00-0.21-0.05-0.04-0.53-0.04-0.09
Cash from Financing Activities181.64178.300.500.031.908.18717.38299.69116.47
Net Change in Cash21.7441.79-117.5795.07-541.08-212.89738.78123.5486.86
Free Cash Flow-159.90-136.51-117.72-195.61-253.82-245.57-90.43-39.58-29.61
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments125.90169.53209.8672.04104.17138.85
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets5.465.734.953.693.753.83
Total Current Assets131.36175.26214.8275.73107.92142.69
Net Property, Plant & Equipment110.61115.89121.86127.48133.96140.38
Total Investments and Advances6.186.186.186.186.186.18
Other Assets8.668.688.678.688.668.66
Total Assets256.81306.01351.53218.07256.73297.91
Short Term Debt Incl. Current Port. of LT Debt9.8111.6612.0611.7511.2910.95
Accounts Payable12.6411.3412.8610.375.066.54
Other Current Liabilities30.3226.5720.6120.3014.6713.38
Total Current Liabilities52.7749.5745.5342.4331.0130.88
Long Term Debt142.94144.33147.12150.45153.92156.69
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.001.501.501.501.50
Total Liabilities195.72193.91194.15194.38186.44189.07
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity61.10112.10157.3823.6970.29108.84
Total Shareholders Equity61.10112.10157.3823.6970.29108.84
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity61.10112.10157.3823.6970.29108.84
Total Liabilities & Stockholders Equity256.81306.01351.53218.07256.73297.91
Book Value Per Share0.971.802.550.451.332.06
Tangible Book Value Per Share0.971.802.550.451.332.06
Full-Time Employees--124---
Price to Book Ratio112.4414.9662.5512.301.810.98
Return on Assets-94.25-76.39-66.94-73.58-60.71-52.04
Return on Equity-368.37-208.80-149.49-207.92-140.33-108.92
Return on Invested Capital-32.17-22.68-18.63-35.29-24.22-21.64
Quick Ratio2.493.544.721.783.484.62
Current Ratio2.493.544.721.783.484.62

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-65.64-58.16-56.74-61.46-54.31-57.46
Depreciation6.196.346.516.546.546.73
Other Funds (Non Cash)11.6112.1513.3014.0515.6417.81
Funds from Operations-47.85-39.66-36.92-40.87-32.13-32.92
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.61-0.35-2.457.99-2.543.85
Cash from Operating Activities-46.24-40.01-39.38-32.88-34.67-29.08
Capital Expenditures-0.35-0.94-0.04-0.06-0.13-0.27
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.35-0.94-0.04-0.06-0.13-0.27
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock2.960.62177.250.810.120.12
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock2.960.62177.250.810.120.12
Proceedsfrom Stock Options0.11-0.30173.060.000.080.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities2.960.62177.250.810.120.12
Net Change in Cash-43.63-40.33137.82-32.13-34.69-29.22
Free Cash Flow-46.59-40.95-39.42-32.94-34.81-29.35

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3014.12%8.1M57.5M1.69M
2026-10-1514.79%8.5M57.5M1.63M
2026-09-3016.31%9.4M57.5M1.43M
2026-09-1518.35%10.7M58.2M678.16K
2026-08-3118.54%10.8M58.1M707.08K
2026-08-1417.72%10.3M58.1M714.94K
2026-07-3117.67%10.2M57.9M722.14K
2026-07-1517.99%10.4M57.9M741.97K
2026-06-3018.36%10.6M57.9M842.51K
2026-06-1518.10%10.5M57.9M1.09M
2026-05-2917.84%10.3M57.9M1.05M
2026-05-1517.64%10.2M57.9M1.07M
2026-04-3017.74%10.2M57.8M1.07M
2026-04-1518.08%10.3M57.1M1.09M
2026-03-3117.16%9.9M57.4M1.03M
2026-03-1312.43%7.0M56.7M807.31K
2026-02-2712.44%7.0M56.7M820.01K
2026-02-1312.14%6.9M56.7M840.07K
2026-01-3012.84%7.3M57.0M859.15K
2026-01-1512.51%7.1M57.0M937.39K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call20.0087.8091.500.008.1380.000.000.998-0.0280.001
call25.0082.7086.5065.307.0571.000.000.998-0.0280.001
call26.0081.7085.500.006.8720.000.000.998-0.0280.001
call27.0080.7084.500.006.6950.000.000.998-0.0280.001
call28.0079.7083.5071.576.5261.000.000.998-0.0280.001
call29.0078.2082.500.006.3640.000.000.997-0.0280.001
call30.0077.2081.5061.436.20840.000.000.997-0.0290.001
call31.0076.2080.5057.696.0591.000.000.997-0.0290.001
call32.0075.5079.5064.825.91531.000.000.997-0.0290.001
call33.0074.7078.5055.755.7762.000.000.997-0.0290.001
call34.0073.7077.5059.445.64220.000.000.997-0.0290.001
call35.0072.1076.5058.475.51226.000.000.997-0.0290.002
call36.0071.5075.5057.235.38614.000.000.997-0.0290.002
call37.0070.8074.5056.285.26414.000.000.997-0.0290.002
call38.0069.8073.500.005.1461.000.000.997-0.0290.002
call39.0068.8072.5052.605.0321.000.000.997-0.0290.002
call40.0067.7071.5042.354.92031.000.000.997-0.0290.002
call41.0066.7070.5050.204.8128660.000.997-0.0290.002
call45.0062.7066.5047.004.4069.000.000.996-0.0300.002
call50.0057.5061.5050.703.9503.000.000.996-0.0300.002
call55.0052.8056.500.003.5400.000.000.995-0.0300.002
call60.0047.5051.5031.603.1661.000.000.995-0.0300.003
call65.0042.5046.500.002.8210.000.000.994-0.0300.003
call70.0037.5041.5026.202.5012,4810.000.962-0.1460.014
call75.0032.6036.5030.002.2003.000.000.935-0.2220.022
call80.0028.4032.0026.302.06061.000.000.926-0.2140.024
call85.0022.9027.0010.251.77499.000.000.911-0.2110.027
call90.0018.8022.5019.801.61034010.000.894-0.1990.031
call95.0014.3017.1017.151.2451,47211.000.836-0.2480.042
call10010.5013.0011.601.13282810.000.750-0.3050.054
call1056.609.509.121.06368014.000.639-0.3480.064
call1104.208.406.251.27780617.000.526-0.4640.068
call1153.004.104.000.93564910.000.403-0.3720.066
call1200.503.402.851.06081411.000.318-0.3680.061
call1250.051.901.720.9842684.000.214-0.2790.050
call1300.301.351.101.02414.002.000.158-0.2400.041
call1350.002.100.051.16725.000.000.143-0.2560.038
call1400.000.950.461.18210.001.000.106-0.2100.031
call1450.004.900.101.3006.000.000.099-0.2190.030
put20.000.000.050.024.03636.000.00-0.002-0.0230.001
put25.000.000.050.053.5103930.00-0.002-0.0230.001
put26.000.000.050.153.4183.000.00-0.002-0.0230.001
put27.000.000.050.203.3302.000.00-0.002-0.0230.001
put28.000.000.056.103.2457.000.00-0.002-0.0230.001
put29.000.004.900.003.3570.000.00-0.002-0.0250.001
put30.000.000.050.013.08543.000.00-0.003-0.0230.001
put31.000.000.050.013.00919.000.00-0.003-0.0230.001
put32.000.000.050.012.93527.000.00-0.003-0.0230.002
put33.000.000.050.052.86417.000.00-0.003-0.0230.002
put34.000.004.900.202.9720.000.00-0.003-0.0250.001
put35.000.002.000.002.8350.000.00-0.003-0.0240.002
put36.000.004.900.002.8340.000.00-0.003-0.0250.002
put37.000.004.900.002.7680.000.00-0.003-0.0250.002
put38.000.004.900.002.6970.000.00-0.003-0.0250.002
put39.000.000.600.502.63516.000.00-0.003-0.0250.002
put40.000.002.151.502.5744.000.00-0.003-0.0250.002
put41.000.000.800.052.52040.000.00-0.003-0.0240.002
put45.000.000.300.052.2314600.00-0.004-0.0240.002
put50.000.000.250.112.0341130.00-0.004-0.0240.002
put55.000.000.050.202.1735.000.00-0.019-0.0900.008
put60.000.000.750.101.5921800.00-0.005-0.0240.003
put65.000.000.050.051.39778.0075.00-0.006-0.0230.003
put70.000.000.500.181.75216914.00-0.038-0.1380.014
put75.000.002.000.251.7643820.00-0.065-0.2140.022
put80.000.000.950.601.5212,8620.00-0.074-0.2050.024
put85.000.001.150.601.30653745.00-0.089-0.2020.027
put90.000.501.000.801.07922624.00-0.106-0.1890.031
put95.000.401.551.251.01020747.00-0.164-0.2380.042
put1000.502.602.260.95817131.00-0.250-0.2940.054
put1053.504.003.800.89769.00120-0.361-0.3360.064
put1104.007.805.971.1072.001.00-0.474-0.4520.068
put1157.0011.0029.701.1401.000.00-0.597-0.3590.066
put12011.0014.7030.871.1831.000.00-0.682-0.3550.061
put12515.0019.0043.501.2730.000.00-0.786-0.2650.050
put13019.5023.3040.171.3257.000.00-0.842-0.2260.041
put13524.0028.000.001.4250.000.00-0.857-0.2410.038
put14029.0033.0046.301.5720.000.00-0.894-0.1940.031
put14534.0038.000.001.7100.000.00-0.901-0.2030.030

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-23SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-21144Filing for proposed sale of securities under Rule 144.SEC
2026-10-20S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersSEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-30SCHEDULE 13D/ASEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-288-KCurrent report2026-09-28SEC
2026-08-14SCHEDULE 13GSEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-04144Filing for proposed sale of securities under Rule 144.SEC
2026-06-048-KCurrent report2026-06-02SEC
2026-05-15SCHEDULE 13GSEC
2026-05-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-04-27SCHEDULE 13GSEC
2026-04-23ARSAnnual report to security holders. 2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1124.34M200
2026-10002.70M1
2026-09156.99M400
2026-080000
2026-070000
2026-06001.02M1
2026-050000
2026-04001.20M1
2026-030000
2026-020000
2026-010000
2025-1260.00M100
2025-110000

Institutional holders

Manager% owned
BAKER BROS. ADVISORS LP31.83%
BlackRock, Inc.6.61%
PRICE T ROWE ASSOCIATES INC /MD/5.19%
STATE STREET CORP3.87%
GOLDMAN SACHS GROUP INC3.70%
VANGUARD CAPITAL MANAGEMENT LLC2.88%
BRAIDWELL LP2.86%
Jupiter Topco LLC2.44%
RTW INVESTMENTS, LP2.38%
Boxer Capital Management, LLC2.36%

Funds

Fund% owned
State Street(R) SPDR(R) S&P(R) Biotech ETF2.39%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.06%
iShares Russell 2000 ETF1.63%
T. Rowe Price Health Sciences Fund, Inc.1.62%
Artisan International Small-Mid Fund0.95%
T. Rowe Price New Horizons Fund, Inc.0.94%
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund0.80%
VANGUARD EXTENDED MARKET INDEX FUND0.76%
Fidelity Small Cap Index Fund0.69%
T. Rowe Price Small-Cap Stock Fund, Inc.0.68%

OakChart. KOD. Cached 15 minutes.